Distinct transcriptomic and exomic abnormalities within myelodysplastic syndrome marrow cells

Area of Science:

• Hematology
• Molecular Biology
• Genomics

Background:

• Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
• Understanding the molecular mechanisms of MDS is crucial for diagnosis and treatment.

Purpose of the Study:

• To elucidate the biologic insights into the mechanisms underlying myelodysplastic syndromes (MDS).
• To identify gene expression profiles (GEPs) that can classify MDS and predict disease progression.

Main Methods:

• High-throughput RNA sequencing (RNA-Seq) was used to evaluate the transcriptome of CD34+ marrow cells from MDS patients and normal controls.
• Differential gene expression analysis and clustering of GEPs were performed.
• Exomic analysis was combined with transcriptomic data.

Main Results:

• Significant differential gene expression profiles were identified between MDS and normal samples, with 41 disease classifier genes identified.
• Two main clusters of GEPs distinguished patients based on clinical features, particularly disease stability versus transformation to acute myeloid leukemia within 12 months.
• Genes associated with disease outcome were involved in MDS-relevant pathways. Differential isoform usage of genes in MDS mutational subgroups was observed, leading to dysregulated biologic functions.

Conclusions:

• The study provides valuable understanding of the mechanisms underlying MDS and its progression to a more aggressive stage.
• The identified GEPs and gene expression patterns facilitate prognostic characterization of MDS patients.
• Combined transcriptomic and exomic findings offer insights into MDS pathogenesis.